Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversiesJosé María García Ruiz de Morales, Miguel Á. González‐Gay, L. Puig et al.|Autoimmunity Reviews|2019Cited by 334
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Raquel Celis, Nora Ng et al.|The Lancet|2021Cited by 315
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trialFelice Rivellese, Raquel Celis, Anna E. A. Surace et al.|Nature Medicine|2022Cited by 277
Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon γ is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathiesJuan D. Cañete|Annals of the Rheumatic Diseases|2000Cited by 184
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trialJürgen Rech, Georg Schett, Koray Taşçılar et al.|The Lancet|2024Cited by 134